Market Overview:
The global bioinert ceramic market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for bioinert ceramic in medical applications, such as heart valves, sutures, and pacemaker electrodes. In addition, the growing awareness about the benefits of using bioinert ceramics over traditional metals is also contributing to the growth of this market. Based on type, the global bioinert ceramic market can be segmented into Al2O3 and ZrO2. Al2O3 is expected to account for a larger share of this market than ZrO2 during the forecast period. Based on application, this market can be segmented into medical implants and surgical instruments. Medical implants are expected to account for a larger share of this market than surgical instruments during the forecast period. Regionally, North America is projected to lead the global bioinert ceramic market during 2018-2030 owing to factors such as technological advancements in medical devices and rising demand from end-use industries such as healthcare and automotive sectors in countries such as U S A .
Product Definition:
Bioinert ceramic is a type of inert material that is used in medical implants and other medical devices. It is made from a biocompatible ceramic material that does not react with the body tissues or fluids. This makes it ideal for use in medical implants, as it reduces the risk of infection or adverse reaction. Bioinert ceramic is also non-toxic, making it safe for use in implantable devices.
Al2O3:
Al2O3 is a ceramic material, which has wide usage in the bio-inert market. It is also used as an additive to increase the hardness and strength of other ceramics. The product helps in controlling thermal expansion, corrosion resistance and heat dissipation properties of materials it’s added to.
ZrO2:
Zirconium Oxide is a ceramic material, which has wide range of applications in bioinert ceramics. It is also known as zirconia or zrO2. ZrO2 has high thermal stability and can withstand high temperatures than most other materials such as silicon dioxide or glass. The material also shows low chemical reactivity and it’s surface area is smaller than that of glass but larger than that of SiC or Si3N4.
Application Insights:
The global market is segmented by application into heart valve, suture, pacemaker electrode and other applications. In 2017, the heart valve was the largest application segment with a share of over 40% in terms of revenue. The growth can be attributed to increasing usage of bioinert ceramics as scaffolds for tissue engineering and regenerative medicine.
Bioinert ceramic materials are used as structural components in various devices such as stents, coronary intervention devices and drug delivery systems owing to their biocompatibility along with superior mechanical properties such as strength-to-weight ratio and stiffness compared to metallic counterparts. These unique characteristics have led to increased demand across multiple medical applications worldwide including stent grafts/vessel closure device implantation sites that require rapid healing without any adverse effects on surrounding tissues or organs due to its non-metallic nature.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position through the forecast period on account of increasing geriatric population and prevalence of cardiovascular diseases, which are majorly treated by bioinert ceramics. In addition, growing medical tourism industry in countries such as U.S., Canada, and Mexico is expected to drive demand for technologically advanced products over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to rising disposable income coupled with improving healthcare infrastructure in emerging economies such as India and China. These factors are likely to contribute toward increased product adoption across various applications during the projected time frame. Moreover, rapid industrialization along with availability of low-cost raw materials from recycled sources will further propel regional market development during this study period (2018 - 2030).
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 7.8% from 2016 to 2021. This is primarily due to the increasing number of geriatric population, rising prevalence of chronic diseases, and technological advancements in surgical procedures. Bioinert ceramic implants are increasingly being used in minimally invasive surgeries as they are biocompatible and do not cause any adverse effects on the patients.
- Growing demand for dental implants: The global dental implant market is projected to grow at a CAGR of 9% from 2016 to 2021 owing to the increasing incidence of oral diseases and rising awareness about dental care among consumers across the globe. Bioinert ceramic implants are increasingly being used as substitutes for traditional metal-based implants as they are biocompatible and do not corrode over time like metal-based implants often do.
- Rising demand for orthopedic implants: The global orthopedic implant market is expected to grow at a CAGR of 6% from 2016 to 2021 due to the increasing incidence of bone fractures, arthritis, and other musculoskeletal disorders across the globe .Bioinert ceramic Implants offer several advantages over traditional metal-based orthopedic implants such as low weight, high strength-to-weight ratio, corrosion resistance etc., which has led them gain popularity among surgeons worldwide .
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioinert Ceramic Market Research Report
By Type
Al2O3, ZrO2
By Application
Heart Valve, Suture, Pacemaker Electrode
By Companies
Biomet, Inc. (US), BASF Corporation (US), AdvanSource Biomaterials Corporation (US), Morgan Technical Ceramics (UK), Nobel Biomaterials, Inc. (US), Stryker Corporation (US), Celanese Corporation (US), BonAlive Biomaterials, Ltd. (Finland), BioMimetic Therapeutics LLC (US), Invibio Biomaterial Solutions (UK), Zimmer Biomet Holdings, Inc, Amedica Corporation, Nobel Biocare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global Bioinert Ceramic Market Report Segments:
The global Bioinert Ceramic market is segmented on the basis of:
Types
Al2O3, ZrO2
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Heart Valve, Suture, Pacemaker Electrode
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biomet, Inc. (US)
- BASF Corporation (US)
- AdvanSource Biomaterials Corporation (US)
- Morgan Technical Ceramics (UK)
- Nobel Biomaterials, Inc. (US)
- Stryker Corporation (US)
- Celanese Corporation (US)
- BonAlive Biomaterials, Ltd. (Finland)
- BioMimetic Therapeutics LLC (US)
- Invibio Biomaterial Solutions (UK)
- Zimmer Biomet Holdings, Inc
- Amedica Corporation
- Nobel Biocare
Highlights of The Bioinert Ceramic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Al2O3
- ZrO2
- By Application:
- Heart Valve
- Suture
- Pacemaker Electrode
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioinert Ceramic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioinert ceramic is a type of ceramic that is made with bioactive materials. Bioinert ceramics are designed to improve the performance of medical devices by reducing the amount of waste that is produced.
Some of the major companies in the bioinert ceramic market are Biomet, Inc. (US), BASF Corporation (US), AdvanSource Biomaterials Corporation (US), Morgan Technical Ceramics (UK), Nobel Biomaterials, Inc. (US), Stryker Corporation (US), Celanese Corporation (US), BonAlive Biomaterials, Ltd. (Finland), BioMimetic Therapeutics LLC (US), Invibio Biomaterial Solutions (UK), Zimmer Biomet Holdings, Inc, Amedica Corporation, Nobel Biocare.
The bioinert ceramic market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bioinert Ceramic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bioinert Ceramic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bioinert Ceramic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bioinert Ceramic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bioinert Ceramic Market Size & Forecast, 2020-2028
4.5.1 Bioinert Ceramic Market Size and Y-o-Y Growth
4.5.2 Bioinert Ceramic Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Al2O3
5.2.2 ZrO2
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Heart Valve
6.2.2 Suture
6.2.3 Pacemaker Electrode
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bioinert Ceramic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bioinert Ceramic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Al2O3
9.6.2 ZrO2
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Heart Valve
9.10.2 Suture
9.10.3 Pacemaker Electrode
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Al2O3
10.6.2 ZrO2
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Heart Valve
10.10.2 Suture
10.10.3 Pacemaker Electrode
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Al2O3
11.6.2 ZrO2
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Heart Valve
11.10.2 Suture
11.10.3 Pacemaker Electrode
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Al2O3
12.6.2 ZrO2
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Heart Valve
12.10.2 Suture
12.10.3 Pacemaker Electrode
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Al2O3
13.6.2 ZrO2
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Heart Valve
13.10.2 Suture
13.10.3 Pacemaker Electrode
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bioinert Ceramic Market: Competitive Dashboard
14.2 Global Bioinert Ceramic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biomet, Inc. (US)
14.3.2 BASF Corporation (US)
14.3.3 AdvanSource Biomaterials Corporation (US)
14.3.4 Morgan Technical Ceramics (UK)
14.3.5 Nobel Biomaterials, Inc. (US)
14.3.6 Stryker Corporation (US)
14.3.7 Celanese Corporation (US)
14.3.8 BonAlive Biomaterials, Ltd. (Finland)
14.3.9 BioMimetic Therapeutics LLC (US)
14.3.10 Invibio Biomaterial Solutions (UK)
14.3.11 Zimmer Biomet Holdings, Inc
14.3.12 Amedica Corporation
14.3.13 Nobel Biocare
